The Mayo Clinic Department of Ophthalmology-Research is a recognized national leader in eye and vision research, translating discoveries into new treatments for cornea diseases, glaucoma and low vision.
The Department of Ophthalmology-Research at Mayo Clinic has a rich history of conducting research in eye disease.
The mentors of today's clinicians and scientists were recognized national leaders who established a tradition of quality and integrity in vision research. This tradition continues today among the leaders of the Department of Ophthalmology-Research and the next generation of vision scientists.
Physician-scientists in our department engage in extensive research activities and collaborate on investigations with other major ophthalmology research centers.
Research in the Department of Ophthalmology-Research occurs at several levels:
- Laboratory-based research
- Eye disease treatment
- Retrospective studies with medical records
This research section in the Department of Ophthalmology-Research has laboratory-based research groups that have been funded for decades by the National Institutes of Health and other supporters of eye research, such as Research to Prevent Blindness.
Research work in these laboratories is directed at delineating the physiology, cellular mechanisms and genetic control of both normal ocular functions, such as the maintenance of corneal clarity, and eye and vision diseases, such as glaucoma and macular degeneration.
Research activities translate into better therapies for patients with these diseases and other eye and vision conditions.
Eye disease treatment
Physicians and scientists in our department are also investigating methods to improve surgical and nonsurgical treatment of eye disease.
Our researchers are pursuing the development of new drugs for retinal disease and analyzing methods to improve corneal transplantation procedures and the surgical correction of nearsightedness.
Many studies in the Department of Ophthalmology-Research are done within a working partnership with medical industries developing new drugs or devices. Some studies are conducted simultaneously with other leading ophthalmology centers around the United States in an effort to define the best treatment of common eye conditions, including macular degeneration in older adults and conditions affecting the developing visual system of children.
Retrospective studies with medical records
Another level of research leverages Mayo Clinic's extensive medical record-keeping system.
Our researchers have undertaken a variety of comprehensive, retrospective studies in order to better understand the natural course of eye disease, the long-term outcomes of disease treatment and trends in the frequency of eye-related illness.
With the involvement of Mayo Clinic colleagues specializing in epidemiology and biostatistics, the Department of Ophthalmology-Research has added essential information to the core of knowledge required by eye care physicians to understand how eye disease affects patients and how treatment can improve the quality of life.
- Sophie J. Bakri, M.D., is chair of the Department of Ophthalmology. Dr. Bakri is an ophthalmologist at Mayo Clinic in Rochester, Minnesota, and a professor of ophthalmology at Mayo Clinic College of Medicine and Science in Rochester. Read more about Dr. Bakri.
- Michael P. Fautsch, Ph.D., is research chair of the Department of Ophthalmology. Dr. Fautsch is a professor of biochemistry and molecular biology and a professor of ophthalmology in the College of Medicine and Science in Rochester. Read more about Dr. Fautsch.